FDA Inspection 1277838 — Children's Hospital of Philadelphia

Children's Hospital of Philadelphia — FEI 2571772

The FDA completed an inspection of Children's Hospital of Philadelphia on July 17, 2025 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Philadelphia, PA (United States)